Skip to main content
All

Search Results

Showing 1 - 8 of 8 Results
Advisory Pharmaceuticals & Biotech December 5, 2024
Government Enforcers Keep Their Sights Trained on Telehealth Providers

The COVID-19 pandemic ushered in the expanded use of telehealth platforms and services, which continues today. Yet increased telehealth activity has also led to increased enforcement efforts against those who — in the government’s view — exploit these platforms unlawfully.  

Lee M. Cortes, Jr., Murad Hussain, Raqiyyah Pippins, Alex Potcovaru, Ada Ohanenye
» Learn More
Blog Europe June 13, 2024
Court of Appeal Rules on Suspension of UKCA Certificates
Jacqueline Mulryne, Christopher Bates
» Learn More
Advisory Global Life Sciences August 2, 2023
Congress Responds to the Proposed Transitional Coverage for Emerging Technologies Medicare Pathway
Congress has been closely following both the Trump and Biden administration’s proposals for Medicare coverage for FDA-designated breakthrough devices.
Bobby McMillin, Monique Nolan, M.D., J.D., Dorothy Isgur
» Learn More
Advisory Global Life Sciences February 17, 2023
China Proposes to Prohibit Export of Certain Human Cell Cloning and Gene Editing Technologies
On December 30, 2022, China’s Ministry of Commerce (MOFCOM) published a proposed version of the Catalogue of Technologies Prohibited and Restricted from Export (Proposed Catalogue) for public comment, adding human cell cloning and gene editing technology to the prohibited list, and certain biotechnology used in drug manufacturing to the restricted list. 
Andrew Shaoyu Chen, Betty Yan, Alex Wang
» Learn More
Advisory Corporate & Finance January 25, 2023
FTC Proposes Rules Which Would Limit Noncompetes
In response to President Biden’s July 2021 Executive Order on Promoting Competition in the American Economy, on January 5, 2023, the Federal Trade Commission promulgated a proposed rule which generally bans all non-competition clauses with workers (including employees and independent contractors) as unfair methods of competition, subject to a limited sale of business exception.
Dipanwita Deb Amar, Uri Horowitz, David J. Reis, Kathleen Wechter, Joel I. Greenberg, Douglas S. Pelley, Kathryn Geoffroy
» Learn More
Advisory Technology January 25, 2023
What Does the Proposed FTC Ban on Noncompete Clauses Mean For Your Business?
On January 5, 2023, in response to the Biden Administration’s July 2021 executive order, the Federal Trade Commission proposed a new rule which, if finalized, will prohibit employers from imposing or enforcing noncompete clauses in agreements with workers, including employees and independent contractors, nationwide and in almost all contexts (excluding, specifically, provisions relating to certain sales of businesses).
Joshua Blank
» Learn More
Advisory Compliance and Fraud & Abuse Counseling April 29, 2021
A New Federal Umpire: What Healthcare Providers Need to Know About Surprise Medical Billing under the No Surprises Act
Catherine A. Brandon, Casey Brouhard, Alana Reid
» Learn More
Advisory Securities Enforcement & Litigation November 18, 2020
Securities Enforcement and Litigation Trends Affecting Life Sciences Companies in 2020
Veronica E. Callahan, Daniel M. Hawke, Jeremy Kamras, Arthur Luk, Joshua R. Martin
» Learn More

Filters